0001209191-21-071193.txt : 20211223
0001209191-21-071193.hdr.sgml : 20211223
20211223210016
ACCESSION NUMBER: 0001209191-21-071193
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211222
FILED AS OF DATE: 20211223
DATE AS OF CHANGE: 20211223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Chad M
CENTRAL INDEX KEY: 0001524314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38957
FILM NUMBER: 211518709
MAIL ADDRESS:
STREET 1: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION
STREET 2: 1551 EASTLAKE AVENUE E STE 200
CITY: SEATTLE
STATE: WA
ZIP: 98101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp
CENTRAL INDEX KEY: 0001478320
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270907024
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1165 EASTLAKE AVE E
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-659-0067
MAIL ADDRESS:
STREET 1: 1165 EASTLAKE AVE E
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptive TCR Corp
DATE OF NAME CHANGE: 20091209
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-22
0
0001478320
Adaptive Biotechnologies Corp
ADPT
0001524314
Cohen Chad M
C/O ADAPTIVE BIOTECHNOLOGIES CORP.
1165 EASTLAKE AVENUE E
SEATTLE
WA
98109
0
1
0
0
Chief Financial Officer
Common Stock
2021-12-22
4
M
0
10000
7.27
A
31604
D
Common Stock
2021-12-22
4
S
0
10000
30.00
D
21604
D
Stock Option (Right to Buy)
7.27
2021-12-22
4
M
0
10000
0.00
D
2029-02-07
Common Stock
10000
80000
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
/s/ Chad Cohen by Eric Billings, Attorney-in-Fact
2021-12-23